XML 62 R38.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stock-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2014
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award                
Expense incurred for stock-based compensation plans   $ 11.8     $ 10.1 $ 32.1 $ 29.4  
Expense incurred for stock-based compensation plans, net of tax   $ 8.8     7.5 $ 23.9 21.6  
Stock Options                
Stock option activity                
Options outstanding at the beginning of the period (in shares)   32,226,210 27,044,960 27,787,920   27,787,920    
Options granted (in shares)   112,000 6,286,200 92,000        
Options exercised (in shares)   (146,400) (1,006,630) (742,280)        
Options forfeited (in shares)   (141,300) (98,320) (92,680)        
Options outstanding at the end of the period (in shares) 27,787,920 32,050,510 32,226,210 27,044,960   32,050,510   27,787,920
Vested and non-vested options expected to vest at the end of the period (in shares)   29,433,574       29,433,574    
Exercisable at the end of the period (in shares)   14,625,670       14,625,670    
Weighted Average Exercise Price                
Weighted average exercise price, options outstanding at the beginning of the period (in dollars per share)   $ 37.20 $ 31.95 $ 31.60   $ 31.60    
Weighted average exercise price, options outstanding at the end of the period (in dollars per share) $ 31.60 37.27 $ 37.20 $ 31.95   37.27   $ 31.60
Weighted average exercise price, vested and non-vested options expected to vest (in dollars per share)   36.69       36.69    
Weighted average exercise price, exercisable (in dollars per share)   $ 26.61       $ 26.61    
Weighted Average Remaining Contractual Term                
Weighted average remaining contractual term of options outstanding   7 years 1 month 6 days 7 years 4 months 2 days 6 years 10 months 28 days       7 years 1 month 2 days
Weighted average remaining contractual term of options vested options and non-vested expected to vest   7 years 4 days            
Weighted average remaining contractual term of options exercisable   5 years 6 months 7 days            
Aggregate Intrinsic Value                
Aggregate intrinsic value of options outstanding $ 617.2 $ 483.2 $ 669.4 $ 729.7   $ 483.2   $ 617.2
Aggregate intrinsic value of options, vested and non-vested options expected to vest   458.7       458.7    
Aggregate intrinsic value of options exercisable   $ 356.1       $ 356.1    
Status of the Company's non-vested options and changes during the year                
Non-vested options at the beginning of the period (in shares)   17,502,480 16,412,880 16,440,560   16,440,560    
Non-vested options, options granted (in shares)   112,000 6,286,200 92,000        
Non-vested options, options vested (in shares)   (48,340) (5,098,280) (27,000)        
Non-vested options, options forfeited (in shares)   (141,300) (98,320) (92,680)        
Non-vested options at the end of the period (in shares) 16,440,560 17,424,840 17,502,480 16,412,880   17,424,840   16,440,560
Weighted Average Fair Value at Grant Date                
Weighted average fair value at the grant date, options outstanding at the beginning of the period (in dollars per share)   $ 8.24 $ 7.99 $ 7.98   $ 7.98    
Weighted average fair value at grant date, options granted (in dollars per share)   7.65 8.49 10.30        
Weighted average fair value at grant date, options vested (in dollars per share)   8.56 7.69 9.51        
Weighted average fair value at grant date, options forfeited (in dollars per share)   8.13 8.09 7.94        
Weighted average fair value at the grant date, options outstanding at the end of the period (in dollars per share) $ 7.98 $ 8.24 $ 8.24 $ 7.99   $ 8.24   $ 7.98
Fair Value at Grant Date                
Total intrinsic value of stock options exercised   $ 3.9     45.5 $ 61.8 123.9  
Total fair value of stock options vested   0.4     $ 0.2 39.8 $ 37.3  
Total compensation cost related to non-vested options not yet recognized   115.1       $ 115.1    
Weighted average expected amortization period           3 years 6 months 18 days    
Restricted Shares                
Fair Value at Grant Date                
Total compensation cost related to non-vested restricted shares not yet recognized   $ 0.6       $ 0.6    
Weighted average expected amortization period           7 months 21 days    
2000 Employee Option Plan                
Share-based Compensation Arrangement by Share-based Payment Award                
Number of additional stock options that can be granted (in shares)   0       0    
Options exercisable period           10 years    
2009 Employee Option Plan                
Share-based Compensation Arrangement by Share-based Payment Award                
Common Stock reserved for issuance   58,000,000       58,000,000    
Shares available for the granting of additional stock options   18,820,680       18,820,680    
Options ratable vesting period           5 years    
Options exercisable period           10 years    
2004 Directors Option Plan                
Share-based Compensation Arrangement by Share-based Payment Award                
Shares available for the granting of additional stock options   140,000       140,000    
Number of additional stock options expected to be granted (in shares)   0       0    
Options exercisable period           10 years    
2012 Directors Restricted Stock Plan                
Share-based Compensation Arrangement by Share-based Payment Award                
Shares available for the granting of additional stock options   153,974       153,974    
2012 Directors Restricted Stock Plan | Restricted Shares                
Restricted share activity                
Restricted shares outstanding at the beginning of the period (in shares)   17,256 19,032 18,340   18,340    
Restricted shares vested and issued     (19,032)          
Restricted shares granted     17,256 692        
Restricted shares outstanding at the end of the period (in shares) 18,340 17,256 17,256 19,032   17,256   18,340
Fair Value at Grant Date                
Fair value at the grant date, restricted shares outstanding at the beginning of the period (in dollars per share)   $ 57.97 $ 47.98 $ 47.72   $ 47.72    
Fair value of restricted shares vested and issued (in dollar per share)     47.98          
Fair value of restricted shares granted (in dollars per share)     57.97 54.96        
Fair value at the grant date, restricted shares outstanding at the beginning of the period (in dollars per share) $ 47.72 $ 57.97 $ 57.97 $ 47.98   $ 57.97   $ 47.72
Weighted Average Remaining Amortization Term (in years) 4 months 21 days 7 months 21 days 10 months 24 days 1 month 24 days